UK vitiligo registry for adults and children
Part of Skin clinical trials.
This study is creating a registry (a secure database) to track the health and treatment of children and adults with vitiligo in the UK. Joining helps researchers learn more about vitiligo and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clear diagnosis of vitiligo from a skin doctor (dermatologist).
- You are being seen at a hospital or specialist clinic for your vitiligo.
- You (or your parent/guardian if you are a child) are willing to give permission to be in the study.
- You agree to let the study team access your medical records now and in the future.
- You can understand English well enough to fill out questionnaires (or your parent/guardian can help).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks the safety and effectiveness of vitiligo medications over time. It helps doctors learn how well treatments work for adults and teens with nonsegmental vitiligo.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study uses a simple blood test to measure immune system signals (cytokines) that may indicate whether vitiligo is active or stable. The goal is to create a model that helps predict how the disease may progress.
This study looks at how vitiligo affects your daily life, work, and activities. If you are an adult with vitiligo, your answers to a survey will help understand these impacts better.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
Hear when a new Dermatologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.